Moderna Inc. (MRNA) Social Stream
MODERNA INC (MRNA) Price Targets From Analysts
Use the tables below to see what analysts covering MODERNA INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-12 | 15 | $475 | $86 | $257.333 | $146.92 | 75.15% |
| 2021-11-26 | 13 | $475 | $86 | $257.333 | $146.92 | 75.15% |
| 2021-12-10 | 14 | $475 | $86 | $256.769 | $146.92 | 74.77% |
| 2021-12-20 | 13 | $475 | $86 | $256.769 | $146.92 | 74.77% |
| 2022-01-03 | 13 | $475 | $86 | $254.846 | $146.92 | 73.46% |
| 2022-01-10 | 13 | $506 | $86 | $257.23 | $146.92 | 75.08% |
| 2022-01-18 | 13 | $506 | $86 | $257.384 | $146.92 | 75.19% |
| 2022-01-21 | 14 | $506 | $86 | $250.857 | $146.92 | 70.74% |
| 2022-01-27 | 14 | $506 | $86 | $249.071 | $146.92 | 69.53% |
| 2022-01-31 | 14 | $506 | $85 | $253.153 | $146.92 | 72.31% |
| 2022-02-22 | 14 | $506 | $85 | $245.307 | $146.92 | 66.97% |
| 2022-02-25 | 14 | $506 | $81 | $241.923 | $146.92 | 64.66% |
| 2022-03-18 | 14 | $506 | $81 | $240.384 | $146.92 | 63.62% |
| 2022-03-25 | 14 | $506 | $81 | $241.153 | $146.92 | 64.14% |
| 2022-04-07 | 14 | $506 | $80 | $241.077 | $146.92 | 64.09% |
| 2022-05-04 | 14 | $506 | $80 | $241.384 | $146.92 | 64.3% |
| 2022-05-11 | 14 | $506 | $80 | $237.307 | $146.92 | 61.52% |
| 2022-05-23 | 14 | $506 | $80 | $225.461 | $146.92 | 53.46% |
| 2022-06-16 | 14 | $506 | $70 | $224.692 | $146.92 | 52.93% |
| 2022-07-29 | 11 | $506 | $70 | $229.416 | $146.92 | 56.15% |
| 2022-08-01 | 12 | $506 | $77 | $235.909 | $146.92 | 60.57% |
| 2022-08-03 | 12 | $506 | $77 | $230 | $146.92 | 56.55% |
| 2022-08-04 | 12 | $506 | $74 | $230.416 | $146.92 | 56.83% |
| 2022-08-30 | 11 | $506 | $74 | $230.416 | $146.92 | 56.83% |
| 2022-10-12 | 12 | $506 | $74 | $230.416 | $146.92 | 56.83% |
| 2022-10-13 | 13 | $506 | $74 | $233.153 | $146.92 | 58.69% |
| 2022-10-18 | 13 | $506 | $74 | $231.461 | $146.92 | 57.54% |
| 2022-10-21 | 13 | $506 | $101 | $230.461 | $146.92 | 56.86% |
| 2022-11-03 | 13 | $506 | $101 | $227.153 | $146.92 | 54.61% |
| 2022-11-04 | 13 | $506 | $101 | $210.583 | $146.92 | 43.33% |
| 2022-11-08 | 14 | $506 | $101 | $208.692 | $146.92 | 42.04% |
| 2022-11-10 | 14 | $506 | $101 | $202.416 | $146.92 | 37.77% |
| 2022-11-14 | 14 | $506 | $101 | $204.25 | $146.92 | 39.02% |
| 2022-11-15 | 14 | $506 | $101 | $206.75 | $146.92 | 40.72% |
| 2022-12-13 | 14 | $506 | $101 | $207.75 | $146.92 | 41.4% |
| 2022-12-14 | 14 | $506 | $102 | $208.25 | $146.92 | 41.74% |
| 2022-12-16 | 14 | $506 | $102 | $211.5 | $146.92 | 43.96% |
| 2022-12-19 | 14 | $506 | $102 | $220.25 | $146.92 | 49.91% |
| 2023-01-03 | 14 | $506 | $102 | $220.5 | $146.92 | 50.08% |
| 2023-01-09 | 14 | $506 | $102 | $221.583 | $146.92 | 50.82% |
| 2023-01-17 | 14 | $506 | $102 | $224.916 | $146.92 | 53.09% |
| 2023-01-20 | 14 | $506 | $111 | $227.083 | $146.92 | 54.56% |
| 2023-01-23 | 13 | $506 | $111 | $227.636 | $146.92 | 54.94% |
| 2023-01-24 | 13 | $506 | $111 | $227.272 | $146.92 | 54.69% |
| 2023-01-26 | 13 | $506 | $111 | $229.09 | $146.92 | 55.93% |
| 2023-02-08 | 13 | $506 | $111 | $230.09 | $146.92 | 56.61% |
| 2023-02-24 | 13 | $506 | $111 | $228.272 | $146.92 | 55.37% |
| 2023-02-26 | 13 | $506 | $93 | $226.363 | $146.92 | 54.07% |
| 2023-03-01 | 13 | $506 | $93 | $223.09 | $146.92 | 51.84% |
| 2023-03-02 | 14 | $506 | $93 | $221.166 | $146.92 | 50.53% |
| 2023-03-23 | 14 | $506 | $93 | $223.666 | $146.92 | 52.24% |
The Trend in the Analyst Price Target
Over the past 139 days, MRNA's average price target has gone up $13.08.
Over the past 51 weeks, MRNA's average upside potential has been 44.5%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-03-30 | 14 | 506 | 80 | 241.077 | 174.92 | 37.82% |
| 2022-04-22 | 14 | 506 | 80 | 241.384 | 140.34 | 72% |
| 2022-05-04 | 14 | 506 | 80 | 241.384 | 155.05 | 55.68% |
| 2022-08-30 | 11 | 506 | 74 | 230.416 | 135.93 | 69.51% |
| 2022-11-04 | 13 | 506 | 101 | 210.583 | 158.41 | 32.94% |
MRNA Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.07 | 7 | 1 | 5 | 1 | 1 | 14 |
The Trend in the Broker Recommendations
Over the past 33 months, MRNA's average broker recommendation rating worsened by 1.03.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In the context of all US stocks, MODERNA INC's variance in analysts' estimates is lower than -5455.89% of them.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, MODERNA INC's average analyst price target is greater than 5406.52% of them.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, MODERNA INC's number of analysts covering the stock is greater than 4934.25% of them.
- MODERNA INC's upside potential (average analyst target price relative to current price) is greater than 1551.86% of Pharmaceutical Products stocks.
In the Pharmaceutical Products industry, DNLI, ARGX, and CRSP are the three stocks most similar to MODERNA INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
What is the outlook for MRNA? Use POWR Ratings for clearer insight into price direction.